UDG Healthcare Public Limited Co. Notice of Interim Results (9609M)
15 May 2020 - 4:00PM
UK Regulatory
TIDMUDG
RNS Number : 9609M
UDG Healthcare Public Limited Co.
15 May 2020
15 May 2020
UDG Healthcare plc
Notice of Interim Results
UDG Healthcare plc (LSE: UDG), a leading international
healthcare services provider, will be announcing its interim
results for the six months to 31 March 2020 on the morning of
Tuesday 19 May 2020.
In line with current government guidance on social distancing,
the company has decided not to proceed with a physical results
presentation. In place of this, Brendan McAtamney, Chief Executive
Officer, and Nigel Clerkin, Chief Financial Officer, will host a
presentation for analysts and investors via conference call and
audio webcast, to discuss the company's half year results and
provide an update on each of the Group's divisions.
It is suggested participants dial-in at least 15 minutes prior
in order to ensure a timely start to the briefing.
Date: Tuesday 19 May 2020
Time: Presentation commencing at 8:30am. Please dial in at
8.15am.
Conference call registration link:
https://secure.emincote.com/client/udghealthcare/udg003/vip_connect
Please note that questions will only be taken from the
conference call
Webcast registration link:
https://secure.emincote.com/client/udghealthcare/udg003
To view the slides alongside the conference call audio, please
dial in to the conference call, and then follow the link to the
webcast. Once registered and on the main webcast page, click
"Slides Only for Conference Call" underneath Alternative
Stream.
For further information, please contact:
UDG Healthcare plc
Keith Byrne
Head of Investor Relations, Strategy & Corporate
Communications
Tel: +353-1-468-9000
Powerscourt
Lisa Kavanagh / Jack Hickey / Eavan Gannon
/ Ella Morris
udghealthcare@powerscourt-group.com
About UDG Healthcare plc:
UDG Healthcare plc (LON: UDG) is a leading international partner
of choice delivering advisory, communication, commercial, clinical
and packaging services to the healthcare industry, employing over
8,500 people with operations in 26 countries and delivering
services in over 50 countries.
UDG Healthcare plc operates across two divisions: Ashfield and
Sharp.
Ashfield is a global leader in advisory, communication,
commercial and clinical services for the pharmaceutical and
healthcare industries. It focuses on supporting healthcare
professionals and patients at all stages of the product life cycle.
The division provides field and contact centre sales teams,
healthcare communications, patient support, audit, advisory,
medical information and event management services to over 300
healthcare companies.
Sharp is a global leader in contract commercial packaging and
clinical trial packaging services for the pharmaceutical and
healthcare industries, operating from state-of the-art facilities
in the US and Europe.
The company is listed on the London Stock Exchange and is a
constituent of the FTSE 250. For more information, please go to:
www.udghealthcare.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORSFWFDLESSEII
(END) Dow Jones Newswires
May 15, 2020 02:00 ET (06:00 GMT)
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2024 to May 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From May 2023 to May 2024